Möchten Sie immer auf dem neuesten Stand bleiben?

SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent results encompassing efficacy, durability, immune responses and safety Overall response rate for iSCIB1+ was 69% for target HLA type...

The Company achieves a major milestone and value inflection point by demonstrating real-time hydrogen production using its novel ThermoLoop™ heat-based water-splitting system SANTA CLARITA, Calif.,...

ACV’s free digital roundtable helps dealers source more consumer vehicles and boost profits with smarter, data-driven acquisition strategies.

Veteran energy expert to lead technical development and commercialization of the Company’s green hydrogen technology SANTA CLARITA, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- NewHydrogen, Inc....

Eupraxia Pharmaceuticals (NASDAQ:EPRX) (TSX:EPRX) will present at the upcoming investor and scientific conferences in April and May.

Washington, DC, March 21, 2025 (GLOBE NEWSWIRE) -- ThinkCareBelieve's Article on Trump's America, Week 9:  https://thinkcarebelieve.blog/2025/03/21/america-under-trump-week-9/ Other articles with...

GREENWOOD VILLAGE, CO, March 19, 2025 (GLOBE NEWSWIRE) -- Air Methods, a leader in air medical transport, proudly announces a milestone in its critical care education efforts with the release of the...

Morris Plains, NJ, March 06, 2025 (GLOBE NEWSWIRE) -- It’s a good time to be an aviation professional. Demand is high, and supply is low. Options are many. Wages are up. For the first time in...

New York, Jan. 17, 2025 (GLOBE NEWSWIRE) -- PHI Group, Inc. (n/k/a Philux Global Group Inc., www.philuxglobal.com, PHIL), is pleased to announce that the Company is taking strong steps to expedite...

Series C financing co-led by Double Point Ventures and DCVC Bio Proceeds to support the clinical development of VivoVec™ derived in vivo CAR T cells SEATTLE, Jan. 14, 2025 (GLOBE NEWSWIRE) --...